PHARMASSET INC Interest Expense
PHARMASSET INC reported Interest Expense of $1.06 million for the 12-month period ending 2011-09-30, per its 10-K filed 2011-11-14.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2011-11-14
- PHARMASSET INC interest expense for the quarter ending 2011-09-30 was $131.00K, a 72.82% decline year-over-year.
- PHARMASSET INC interest expense for the quarter ending 2011-06-30 was $219.00K, a 61.24% decline year-over-year.
- PHARMASSET INC interest expense for the quarter ending 2010-09-30 was $482.00K.
- PHARMASSET INC interest expense for the quarter ending 2010-06-30 was $565.00K.
- PHARMASSET INC interest expense for fiscal 2011 was $1.06M, a 55.75% decline from fiscal 2010.
- PHARMASSET INC interest expense for fiscal 2010 was $2.39M, a 25.05% decline from fiscal 2009.
- PHARMASSET INC interest expense for fiscal 2009 was $3.19M.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2011-09-30 | $131.00K derived: 10-K 12 month − 10-Q 9 month · filed 2011-11-14 | $350.00K derived: sum of 2 quarters · filed 2011-11-14 | $1.06M 10-K · filed 2011-11-14 | |
| 2011-06-30 | $219.00K 10-Q · filed 2011-08-09 | $927.00K 10-Q · filed 2011-08-09 | ||
| 2010-09-30 | $482.00K derived: 10-K 12 month − 10-Q 9 month · filed 2011-11-14 | $1.05M derived: sum of 2 quarters · filed 2011-11-14 | $2.39M 10-K · filed 2011-11-14 | |
| 2010-06-30 | $565.00K 10-Q · filed 2011-08-09 | $1.91M 10-Q · filed 2011-08-09 | ||
| 2009-09-30 | $3.19M 10-K · filed 2011-11-14 |